HCA Healthcare (HCA) PT Raised to $150.00

Share on StockTwits

HCA Healthcare (NYSE:HCA) had its price objective lifted by Robert W. Baird from $130.00 to $150.00 in a report published on Thursday, September 20th, The Fly reports. The brokerage currently has a positive rating on the stock.

Several other brokerages have also recently issued reports on HCA. SunTrust Banks increased their price target on shares of HCA Healthcare to $150.00 and gave the stock a positive rating in a research report on Tuesday, September 4th. Mizuho set a $150.00 price target on shares of HCA Healthcare and gave the stock a buy rating in a research report on Tuesday, September 4th. Leerink Swann raised their target price on shares of HCA Healthcare from $140.00 to $150.00 and gave the company an outperform rating in a report on Tuesday, September 4th. BMO Capital Markets raised their target price on shares of HCA Healthcare from $145.00 to $155.00 and gave the company a buy rating in a report on Wednesday, September 5th. Finally, Morgan Stanley raised their target price on shares of HCA Healthcare from $115.00 to $124.00 and gave the company an underweight rating in a report on Wednesday, September 5th. Two analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have assigned a buy rating to the company. HCA Healthcare presently has an average rating of Buy and an average price target of $135.19.

Shares of HCA traded up $1.43 during mid-day trading on Thursday, hitting $133.86. 1,454,880 shares of the company’s stock were exchanged, compared to its average volume of 1,908,900. The stock has a market capitalization of $48.14 billion, a PE ratio of 20.31, a P/E/G ratio of 1.23 and a beta of 0.49. HCA Healthcare has a fifty-two week low of $71.18 and a fifty-two week high of $141.11. The company has a debt-to-equity ratio of -7.64, a quick ratio of 1.15 and a current ratio of 1.36.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Wednesday, July 25th. The company reported $2.29 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.16 by $0.13. The business had revenue of $11.53 billion for the quarter, compared to analysts’ expectations of $11.32 billion. HCA Healthcare had a net margin of 6.21% and a negative return on equity of 61.68%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.73 earnings per share. On average, sell-side analysts predict that HCA Healthcare will post 9.23 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, September 28th. Shareholders of record on Tuesday, September 4th were paid a $0.35 dividend. The ex-dividend date of this dividend was Friday, August 31st. This represents a $1.40 annualized dividend and a yield of 1.05%. HCA Healthcare’s dividend payout ratio is currently 21.24%.

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,689 shares of the stock in a transaction that occurred on Wednesday, July 25th. The shares were sold at an average price of $112.53, for a total value of $190,063.17. Following the transaction, the senior vice president now directly owns 10,057 shares in the company, valued at $1,131,714.21. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CMO Jonathan B. Perlin sold 10,000 shares of the stock in a transaction that occurred on Wednesday, July 25th. The shares were sold at an average price of $112.53, for a total transaction of $1,125,300.00. Following the completion of the transaction, the chief marketing officer now owns 105,394 shares in the company, valued at $11,859,986.82. The disclosure for this sale can be found here. Insiders sold 170,257 shares of company stock worth $21,118,053 over the last quarter. 2.80% of the stock is currently owned by insiders.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Bank of Montreal Can grew its position in shares of HCA Healthcare by 58.7% during the third quarter. Bank of Montreal Can now owns 803,092 shares of the company’s stock worth $111,727,000 after acquiring an additional 297,015 shares during the last quarter. DNB Asset Management AS lifted its holdings in shares of HCA Healthcare by 1.1% during the third quarter. DNB Asset Management AS now owns 36,357 shares of the company’s stock worth $5,058,000 after purchasing an additional 413 shares during the period. Fox Run Management L.L.C. lifted its holdings in shares of HCA Healthcare by 99.7% during the third quarter. Fox Run Management L.L.C. now owns 4,497 shares of the company’s stock worth $626,000 after purchasing an additional 2,245 shares during the period. Moon Capital Management LLC acquired a new stake in shares of HCA Healthcare during the third quarter worth $7,392,000. Finally, United Services Automobile Association lifted its holdings in shares of HCA Healthcare by 51.9% during the second quarter. United Services Automobile Association now owns 209,254 shares of the company’s stock worth $21,469,000 after purchasing an additional 71,530 shares during the period. Institutional investors and hedge funds own 70.40% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: What is a Leveraged Buyout (LBO)?

The Fly

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.